ADVANCES IN AUDIOLOGY AND HEARING SCIENCE. VOLUME 2: OTOPROTECTION, REGENERATION AND TELEMEDICINE.

• PART I: HEARING DEVICES
1. Assessment of Early Auditory Development in Children after Cochlear Implantation
2. Hearing Aids for the Pediatric Population
3. Music Therapy as Specific and Complementary Training in the Early Rehabilitation of Adult CI Users: Insights from the “Heidelberg Model”
4. The Active Middle Ear Implant Vibrant Soundbridge: Outcomes on Safety, Efficacy, Effectiveness, and Subjective Benefit 1996–2017
• PART II: HEARING IN THE ELDERLY
5. Cochlear Implants with Elderly Individuals and Quality of Life
6. Screening Tools for Otological Function in Older Adults
• PART III: OTOPROTECTION AND REGENERATION
7. Towards Clinical Pharmacologic Otoprotection
8. Clinical Test Paradigms and Problems: Human Otoprotection Studies
9. Stem Cells and Nanotechnology
10. Tinnitus
• PART IV: TELEMEDICINE
11. Teleaudiology
12. Mhealth Solutions in Hearing Care for Sub-Saharan Africa
13. Teleaudiology Practices in Asia
14. Terms, Regulations, and Concepts in Telehealth and Audiology
Index

With chapters from audiology professionals from around the world, Advances in Audiology and Hearing Science presented in two volumes—provides an abundance of information on the latest technological and procedural advances in this ever-improving field.

Volume 1 primarily focuses on revised clinical protocols and provides information on new research to help guide decisions and criteria regarding diagnosis, management, and treatment of hearing-related issues. Topics include new clinical applications such as auditory steady-state response, wideband acoustic immittance, otoacoustic emissions, frequency following response, noise exposure, genomics and hearing loss, and more.

Volume 2: Otoprotection, Regeneration, and Telemedicine includes sections with material related to hearing devices, hearing in special populations, such as the children and the elderly, as well chapters on the fast-growing subfields of otoprotection and regeneration, including pharmacologic otoprotection, stem cells, and nanotechnology.

Authors
• Stavros Hatzopoulos, PhD, is a faculty member of the Audiology & ENT Clinic, University of Ferrara, Italy.
• Andrea Ciorba, MD, PhD, has been a member of the Audiology & ENT Clinic, University of Ferrara, Italy, since 2004.
• Mark Krumm, PhD, is an associate professor in the School of Speech Pathology and Audiology at Kent State University in Kent, Ohio (USA).